A Study to Evaluate the Awareness and Acceptability of Primary HPV Testing and Self Collection for Cervical Cancer in Patients and Primary Care Physicians

Overview

About this study

The purposes of this study are to assess awareness and acceptability of HPV testing for cervical cancer screening and patient self-collection of vaginal swabs among women aged 30 to 65 years old, to assess awareness and acceptability of HPV testing for cervical cancer screening and patient self-collection of vaginal swabs among primary care clinicians, and to identify insights from regional and national thought leaders in the fields of primary care and cervical cancer screening on strategies to improve uptake of primary HPV screening and opinions on patient self-collection by conducting key informant interviews.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria - Aim 1:

Women aged 30-65 years old.
Qualify for average risk cervical cancer screening; research authorization status; identified as empaneled in the Mayo Clinic Midwest Primary Care database.

Exclusion Criteria - Aim 1:

S/P hysterectomy, in utero DES exposure, history cervical cancer, HIV+, S/P solid organ transplant, on immunosuppressant medication.

Inclusion Criteria - Aim 2:

FM and IM clinicians (MD/DO, APP) and FM residents (MD/DO) in Mayo Clinic Midwest Primary Care practices at time of study administration.

Exclusion Criteria - Aim 2:

Clinicians who do not perform cervical cancer screening tests in their clinical practice.

Inclusion Criteria - Aim 3:

Primary care physician leaders within Mayo Clinic (department chair of Family Medicine, division chair of Community Internal Medicine, director of southeastern Minnesota Primary Care, vice president of operations Mayo Clinic Health System) and national thought leaders in cervical cancer screening identified by their roles in USPSTF, ASCCP and CDC.

Exclusion Criteria - Aim 3:

Conflict of interest related to primary HPV testing platforms.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Kathy MacLaughlin, M.D.	Closed for enrollment	Contact information: Kathy MacLaughlin M.D. (507) 538-8522 MacLaughlin.Kathy@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kathy MacLaughlin, M.D.

Closed for enrollment

Contact information:

Kathy MacLaughlin M.D.

(507) 538-8522

MacLaughlin.Kathy@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials